YTHDC2 and hepatocellular carcinoma: Another SNP within YTHDC2, rs7202116, shows a significant association with the survival of patients with HCC treated with transarterial chemoembolization, particularly with a poor prognosis observed in patients with the rs7202116 GG genotype.